Ionix Pharmaceuticals Ltd.
This article was originally published in Start Up
Executive Summary
Ionix, which was created around IP relating to the discovery of ion channel targets for pain therapeutics, is balancing the risks of discovering novel drugs with programs based on improving or reformulating known analgesics.